Back to Treatments

Treatment

Gemcitabine + Nab-paclitaxel

1
Conditions
396
Trials
2,500
Participants
25%
Average Safety

Condition Evidence

Pancreatic cancer

396 trials · 2,500 participants

75% effectiveness · 25% safety
Gemcitabine + Nab-paclitaxel | DFDA